Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 5 studies | 28% ± 8% | |
hepatocyte | 4 studies | 62% ± 22% | |
epithelial cell | 4 studies | 22% ± 6% | |
renal principal cell | 4 studies | 57% ± 21% | |
cholangiocyte | 3 studies | 45% ± 19% | |
basal cell | 3 studies | 37% ± 22% | |
glutamatergic neuron | 3 studies | 26% ± 8% | |
astrocyte | 3 studies | 41% ± 21% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 51% ± 24% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 943.91 | 221 / 226 | 72% | 4.25 | 291 / 406 |
stomach | 76% | 2569.42 | 274 / 359 | 33% | 5.19 | 93 / 286 |
breast | 60% | 668.63 | 277 / 459 | 46% | 2.47 | 515 / 1118 |
pancreas | 42% | 87.91 | 139 / 328 | 60% | 4.37 | 106 / 178 |
kidney | 91% | 557.58 | 81 / 89 | 8% | 0.94 | 72 / 901 |
esophagus | 38% | 188.82 | 548 / 1445 | 50% | 4.39 | 91 / 183 |
skin | 72% | 1060.82 | 1303 / 1809 | 3% | 0.21 | 14 / 472 |
prostate | 30% | 84.38 | 74 / 245 | 5% | 0.11 | 26 / 502 |
lung | 3% | 5.57 | 16 / 578 | 27% | 2.33 | 312 / 1155 |
intestine | 10% | 34.94 | 93 / 966 | 12% | 1.25 | 62 / 527 |
adrenal gland | 20% | 39.51 | 51 / 258 | 1% | 0.05 | 2 / 230 |
uterus | 4% | 6.54 | 6 / 170 | 14% | 1.30 | 63 / 459 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.89 | 7 / 45 |
brain | 0% | 0.09 | 2 / 2642 | 8% | 0.17 | 57 / 705 |
bladder | 0% | 0 | 0 / 21 | 8% | 0.39 | 38 / 504 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
thymus | 1% | 4.31 | 9 / 653 | 2% | 0.13 | 10 / 605 |
adipose | 3% | 5.60 | 32 / 1204 | 0% | 0 | 0 / 0 |
ovary | 1% | 0.69 | 1 / 180 | 1% | 0.11 | 4 / 430 |
spleen | 0% | 1.54 | 1 / 241 | 0% | 0 | 0 / 0 |
heart | 0% | 0.17 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.57 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_0044788 | Biological process | modulation by host of viral process |
GO_0006935 | Biological process | chemotaxis |
GO_0016477 | Biological process | cell migration |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0035005 | Molecular function | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO_0052742 | Molecular function | phosphatidylinositol kinase activity |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
Gene name | PIK3C2G |
Protein name | PIK3C2G protein Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PI3K-C2-gamma) (PtdIns-3-kinase C2 subunit gamma) (EC 2.7.1.137) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-gamma) Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma |
Synonyms | |
Description | FUNCTION: Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers (By similarity). May play a role in SDF1A-stimulated chemotaxis (By similarity). . |
Accessions | ENST00000546003.5 ENST00000536967.2 F5GWG6 ENST00000676171.1 [O75747-1] ENST00000675017.1 [O75747-1] A0A087WV31 F5H7Y7 ENST00000538779.6 [O75747-1] ENST00000535651.5 ENST00000433979.6 [O75747-2] B7ZLY6 O75747 |